We are live on ! Find out more
MTNB icon

Matinas BioPharma
MTNB

71 hedge funds and large institutions have $57.1M invested in Matinas BioPharma in 2020 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

111% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 9

64% more capital invested

Capital invested by funds: $34.8M → $57.1M (+$22.3M)

16% more funds holding

Funds holding: 61 → 71 (+10)

0.04% less ownership

Funds ownership: 0.46% → 0.42% (-0.04%)

27% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 15

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
11
Reduced
15
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$1.13M
2
PFMOSF
Philadelphia Financial Management of San Francisco
California
+$686K
3
SIG
Sargent Investment Group
Maryland
+$609K
4
ECM
ExodusPoint Capital Management
New York
+$582K
5
Millennium Management
Millennium Management
New York
+$362K

Top Sellers

Rank Fund Capital Flow
1
VC
Vivo Capital
California
-$4.47M
2
Two Sigma Investments
Two Sigma Investments
New York
-$1.27M
3
RJFSA
Raymond James Financial Services Advisors
Florida
-$548K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$385K
5
WIC
Water Island Capital
New York
-$268K
Name Holding Trade Value Shares
Change 		Change in
Stake
BC
1
Boxer Capital
California
$15.6M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$10.5M +$71.8K +1,550 +1%
VC
3
Vivo Capital
California
$8.77M -$4.47M -96,554 -43%
BlackRock
4
BlackRock
New York
$3.05M +$6.34K +137 +0.3%
SIG
5
Sargent Investment Group
Maryland
$1.94M +$609K +13,141 +85%
Renaissance Technologies
6
Renaissance Technologies
New York
$1.66M +$1.13M +24,383 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$1.52M +$38.9K +839 +4%
BCM
8
Bridgeway Capital Management
Texas
$1.46M +$210K +4,530 +27%
Victory Capital Management
9
Victory Capital Management
Texas
$1.39M -$151K -3,255 -14%
Royal Bank of Canada
10
Royal Bank of Canada
Ontario, Canada
$1.1M +$16.6K +359 +2%
PFMOSF
11
Philadelphia Financial Management of San Francisco
California
$1.01M +$686K +14,817 New
ECM
12
ExodusPoint Capital Management
New York
$854K +$582K +12,559 New
CIBC Private Wealth Group
13
CIBC Private Wealth Group
Georgia
$816K – – –
SCA
14
STALEY CAPITAL ADVISERS
Pennsylvania
$816K – – –
Two Sigma Advisers
15
Two Sigma Advisers
New York
$790K -$385K -8,320 -42%
Millennium Management
16
Millennium Management
New York
$597K +$362K +7,807 +803%
MSFS
17
Main Street Financial Solutions
Pennsylvania
$545K +$371K +8,017 New
California Public Employees Retirement System
18
California Public Employees Retirement System
California
$480K – – –
Wells Fargo
19
Wells Fargo
California
$422K -$58.4K -1,261 -17%
DA
20
DCF Advisers
Connecticut
$415K -$228K -4,930 -45%
Northern Trust
21
Northern Trust
Illinois
$374K -$4.77K -103 -2%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$271K – – –
Squarepoint
23
Squarepoint
New York
$221K +$151K +3,257 New
PTP
24
Platform Technology Partners
New York
$216K -$9.72K -210 -6%
LPL Financial
25
LPL Financial
California
$183K +$125K +2,690 New
1
2 3 4

MTNB Hedge Fund Activity: Q4 2020 in Review

71 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Matinas BioPharma (MTNB) for Q4 2020, worth a combined $57.1M — up 64% from $34.8M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new MTNB positions and 9 closed out — a net gain of 10 holders — while 11 added to existing stakes and 15 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $1.13M. The largest seller was Vivo Capital, cutting an estimated $4.47M.

  • 71 institutional investors held Matinas BioPharma (MTNB) as of Q4 2020, up from 61 in Q3 2020.
  • Funds reported $57.1M of Matinas BioPharma stock for Q4 2020, up 64% quarter-over-quarter.
  • 19 funds opened new Matinas BioPharma positions in Q4 2020 and 9 closed out, a net change of +10 holders.
  • The largest Matinas BioPharma buyer in Q4 2020 was Renaissance Technologies, an estimated $1.13M added.
  • The largest Matinas BioPharma seller in Q4 2020 was Vivo Capital, an estimated $4.47M sold.

Based on aggregated 13F filings for Q4 2020.